Uterus and endometrium. Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy

Author： Nisolle Michelle   Gillerot Stéphane   Casanas-Roux Françoise   Squifflet Jean   Berliere Martine  

Publisher： Oxford University Press

ISSN： 1460-2350

Source： Human Reproduction, Vol.14, Iss.11, 1999-11, pp. : 2844-2850

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endocrinology. Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administration

By Friedler S.   Raziel A.   Schachter M.   Strassburger D.   Bukovsky I.  

Human Reproduction, Vol. 14, Iss. 8, 1999-08 ,pp. : 1944-1948

Oxford University Press

Access to resources Recommend Favorite

Histological evaluation of endometrium on the day of oocyte retrieval after gonadotrophin-releasing hormone agonist/follicle stimulating hormone ovulation induction for in-vitro fertilization

By Lass A  

Human Reproduction, Vol. 13, Iss. 11, 1998-11 ,pp. : 3203-3205

Oxford University Press

Access to resources Recommend Favorite

Contraception: Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant ® users

By Lau Tseng M.  

Human Reproduction, Vol. 11, Iss. 12, 1996-12 ,pp. : 2629-2634

Oxford University Press

Access to resources Recommend Favorite

Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission.

By Carmina E   Lobo R A  

Human Reproduction, Vol. 12, Iss. 4, 1997-04 ,pp. : 663-666

Oxford University Press

Access to resources Recommend Favorite

Infertility. Continuous administration of gonadotrophin-releasing hormone agonist during the luteal phase in IVF

By Fujii Shunsaku   Sato Shigemi   Fukui Atsushi   Kimura Hidetaka   Kasai Goichiro  

Human Reproduction, Vol. 16, Iss. 8, 2001-08 ,pp. : 1671-1675

Oxford University Press

Access to resources Recommend Favorite